---
schema_version: "secwatch.filing_event.v1"
accession: "0001388658-22-000149"
form_type: "8-K"
ticker: "IRTC"
cik: "0001388658"
company_name: "iRhythm Holdings, Inc."
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T17:41:51.699454+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# iRhythm Q3 revenue $103.9M (+21.6% YoY); cuts FY22 revenue guidance to $407-411M

## Summary
- Revenue $103.9M (+21.6% YoY); net loss $21.5M ($0.71/sh) vs $23.7M loss in Q3 2021.
- Gross margin 68.3%, up 2.6pp from 65.7% in Q3 2021.
- FY22 revenue guidance lowered to $407-411M from prior $415-420M (approx 26-27% YoY growth).
- Adjusted EBITDA guidance improved to -$10 to -$12M from prior -$12.5 to -$17.5M; adjusted opex guidance $360-365M.
- Registration volumes +22% YoY; highest daily registrations at Sept end; cited softness in returned devices persisting into Q4.

## SEC filing metadata
- accession: 0001388658-22-000149
- form_type: 8-K
- ticker: IRTC
- cik: 0001388658
- company_name: iRhythm Holdings, Inc.
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000149/0001388658-22-000149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000149/irtc-20221101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001388658-22-000149
- JSON: https://secwatch.observer/filing/0001388658-22-000149.json
- Plain text: https://secwatch.observer/filing/0001388658-22-000149.txt

## Key facts
- Earnings Releases
  iRhythm Holdings, Inc. reported the three months ended September 30, 2022 results: revenue $103.9 million, net income Net loss for the third quarter of 2022 was $21.5 million, or a loss of $0.71 per share, EPS $0.71 per share. Guidance lowered.
  - Period: the three months ended September 30, 2022
  - Revenue: $103.9 million
  - Net income: Net loss for the third quarter of 2022 was $21.5 million, or a loss of $0.71 per share
  - EPS: $0.71 per share
  - Guidance: lowered
  - Result: reported results
  source text: that detect, prevent, and predict disease, today reported financial results for the three months ended September 30, 2022. Third Quarter 2022 Financial Results • Revenue of $103.9 million, a 21.6% increase compared to third quarter 2021 • Gross margin of 68.3%, a 2.6 percentage point improvement compared to third quarter 2021 • Cash, cash equivalents and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1388658/000138865822000149/0001388658-22-000149-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.